Cargando…
Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
BACKGROUND/AIM: Few studies have reported the prognostic value of pretreatment hemoglobin levels in patients with lung adenocarcinoma (LA). In the present study, we retrospectively reviewed 306 LA patients for their prognosis associated with the pretreatment hemoglobin levels. METHODS: Person-years...
Autores principales: | Zhang, Yue-Hua, Lu, Yuquan, Lu, Hong, Zhang, Meng-Wei, Zhou, Yue-Min, Li, Xiang-Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977049/ https://www.ncbi.nlm.nih.gov/pubmed/29887927 http://dx.doi.org/10.1155/2018/6328127 |
Ejemplares similares
-
Development of a Survival Prognostic Model for Non-small Cell Lung Cancer
por: Zhang, Yue-Hua, et al.
Publicado: (2020) -
Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer
por: Shin, Na-Ri, et al.
Publicado: (2014) -
Integrated TCGA and GEO analysis showed that SMAD7 is an independent prognostic factor for lung adenocarcinoma
por: Dai, Zhou-Tong, et al.
Publicado: (2020) -
LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR
por: Wang, Lu, et al.
Publicado: (2019) -
Is serum hemoglobin level an independent prognostic factor for IgA nephropathy?: a systematic review and meta-analysis of observational cohort studies
por: Zhang, Kang, et al.
Publicado: (2023)